Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forbes Pharmaceuticals is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of generic pharmaceutical formulations. Headquartered in Mumbai, the company produces various dosage forms, including tablets, capsules, dry syrups, and liquid orals, covering therapeutic segments such as anti-infectives, gastrointestinal agents, analgesics, and nutritional supplements. Forbes Pharmaceuticals operates manufacturing facilities that comply with Good Manufacturing Practices (GMP) and serves both the domestic Indian market and several international territories. In addition to its proprietary product line, the company provides contract manufacturing services to global pharmaceutical partners, focusing on delivering high-quality and cost-effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forbes Pharmaceuticals.